140 related articles for article (PubMed ID: 33455422)
1. Clinical and Demographic Characteristics of Tearing in Patients after Radioiodine Ablation for Differentiated Thyroid Cancer.
Yartsev VD; Solodkiy VA; Fomin DK; Borisenko TE; Atkova EL
Curr Eye Res; 2021 Sep; 46(9):1320-1324. PubMed ID: 33455422
[No Abstract] [Full Text] [Related]
2. Visualization of nasolacrimal drainage system after radioiodine therapy in patients with thyroid cancer.
Sakahara H; Yamashita S; Suzuki K; Imai M; Kosugi T
Ann Nucl Med; 2007 Nov; 21(9):525-7. PubMed ID: 18030585
[TBL] [Abstract][Full Text] [Related]
3. Relationship between radioactive iodine therapy for thyroid carcinoma and nasolacrimal drainage system obstruction.
Cetinkaya A; Kersten RC
Ophthalmic Plast Reconstr Surg; 2007; 23(6):496. PubMed ID: 18030131
[No Abstract] [Full Text] [Related]
4. Topographic and anatomical features of the nasolacrimal duct obstruction due to radioiodine treatment.
Yartsev VD; Atkova EL; Ekaterinchev MA
Int Ophthalmol; 2023 Sep; 43(9):3385-3390. PubMed ID: 37199817
[TBL] [Abstract][Full Text] [Related]
5. [Lacrimal drainage system obstruction associated to radioactive iodine therapy for thyroid carcinoma].
Fonseca FL; Lunardelli P; Matayoshi S
Arq Bras Oftalmol; 2012; 75(2):97-100. PubMed ID: 22760799
[TBL] [Abstract][Full Text] [Related]
6. Nasolacrimal obstruction secondary to I(131) therapy.
Burns JA; Morgenstern KE; Cahill KV; Foster JA; Jhiang SM; Kloos RT
Ophthalmic Plast Reconstr Surg; 2004 Mar; 20(2):126-9. PubMed ID: 15083081
[TBL] [Abstract][Full Text] [Related]
7. Accumulation of 131Iodine in the nasolacrimal sac/duct after radioiodine therapy for papillary thyroid cancer.
Usmani S; Jain A; Al-Riyami K; Abubakar S
J Pak Med Assoc; 2023 Mar; 73(3):713-714. PubMed ID: 36932793
[TBL] [Abstract][Full Text] [Related]
8. Expression of sodium iodide symporter in the lacrimal drainage system: implication for the mechanism underlying nasolacrimal duct obstruction in I(131)-treated patients.
Morgenstern KE; Vadysirisack DD; Zhang Z; Cahill KV; Foster JA; Burns JA; Kloos RT; Jhiang SM
Ophthalmic Plast Reconstr Surg; 2005 Sep; 21(5):337-44. PubMed ID: 16234694
[TBL] [Abstract][Full Text] [Related]
9. Salivary gland dysfunction and nasolacrimal duct obstruction: stenotic changes following I-131 therapy.
Savage MW; Sobel RK; Hoffman HT; Carter KD; Finkelstein MW; Shriver EM
Ophthalmic Plast Reconstr Surg; 2015; 31(3):e50-2. PubMed ID: 24836449
[TBL] [Abstract][Full Text] [Related]
10. Nasolacrimal duct obstruction as a complication of iodine-131 therapy in patients with thyroid cancer.
Fard-Esfahani A; Farzanefar S; Fallahi B; Beiki D; Saghari M; Emami-Ardekani A; Majdi M; Eftekhari M
Nucl Med Commun; 2012 Oct; 33(10):1077-80. PubMed ID: 22825036
[TBL] [Abstract][Full Text] [Related]
11. Dependence of radioactive iodine-131 capture by the lacrimal ducts on the tear production level.
Yartsev VD; Sheremeta MS; Trukhin AA; Atkova EL; Degtyarev MV; Yasyuchenya VS; Yudakov DV
Indian J Ophthalmol; 2023 May; 71(5):1828-1832. PubMed ID: 37203037
[TBL] [Abstract][Full Text] [Related]
12. Etiology of tearing: a retrospective analysis of referrals to a tertiary care oculoplastics practice.
Mainville N; Jordan DR
Ophthalmic Plast Reconstr Surg; 2011; 27(3):155-7. PubMed ID: 20940663
[TBL] [Abstract][Full Text] [Related]
13. Nasolacrimal drainage system obstruction from radioactive iodine therapy for thyroid carcinoma.
Kloos RT; Duvuuri V; Jhiang SM; Cahill KV; Foster JA; Burns JA
J Clin Endocrinol Metab; 2002 Dec; 87(12):5817-20. PubMed ID: 12466391
[TBL] [Abstract][Full Text] [Related]
14. Secondary Acquired Nasolacrimal Duct Obstruction as a Specific Complication of Treatment With Radioactive Iodine (Morphological Study).
Fedorov AA; Atkova EL; Yartsev VD
Ophthalmic Plast Reconstr Surg; 2020; 36(3):250-253. PubMed ID: 31743278
[TBL] [Abstract][Full Text] [Related]
15. Endoscopic dacryocystorhinostomy following radioactive iodine thyroid ablation.
Van Tassel SH; Segal KL; Hsu NM; Kacker A; Lelli GJ
Orbit; 2017 Apr; 36(2):59-63. PubMed ID: 28388347
[TBL] [Abstract][Full Text] [Related]
16. Relationship between lacrimal sac size and duration of tearing in nasolacrimal duct obstruction.
Lee MJ; Kim IH; Choi YJ; Kim N; Choung HK; Khwarg SI
Can J Ophthalmol; 2019 Feb; 54(1):111-115. PubMed ID: 30851763
[TBL] [Abstract][Full Text] [Related]
17. Lacrimal System Obstruction After Radioiodine Therapy in Differentiated Thyroid Carcinomas: A Prospective Comparative Study.
da Fonseca FL; Yamanaka PK; Kato JM; Matayoshi S
Thyroid; 2016 Dec; 26(12):1761-1767. PubMed ID: 27565021
[TBL] [Abstract][Full Text] [Related]
18. Surgical Risk Prediction for Nasolacrimal Duct Obstruction in Radioactive Iodine-Treated Thyroid Cancer: A Nationwide Cohort Study.
Lee JY; Woo KI
Thyroid; 2022 May; 32(5):544-551. PubMed ID: 34894720
[No Abstract] [Full Text] [Related]
19. Epiphora after radioactive iodine ablation for thyroid cancer.
Sun GE; Hatipoglu B
Thyroid; 2013 Feb; 23(2):243-5. PubMed ID: 22946448
[TBL] [Abstract][Full Text] [Related]
20. Effects of Radioiodine Treatment on Salivary Gland Function in Patients with Differentiated Thyroid Carcinoma: A Prospective Study.
Klein Hesselink EN; Brouwers AH; de Jong JR; van der Horst-Schrivers AN; Coppes RP; Lefrandt JD; Jager PL; Vissink A; Links TP
J Nucl Med; 2016 Nov; 57(11):1685-1691. PubMed ID: 27339871
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
